TPE and RAC Audit Support for Sleep Diagnostic Center: PAP Therapy Compliance Documentation

Positive airway pressure therapy coverage under Medicare depends on a structured sequence of documentation milestones spanning the initial diagnostic testing, the twelve-week adherence trial, and continued coverage beyond the initial trial period, and each of these milestones carries its own specific documentation expectations that Targeted Probe and Educate reviews and Recovery Audit Contractor audits frequently examine. Because PAP therapy compliance documentation typically involves both the sleep diagnostic center and the durable medical equipment supplier furnishing the device, a sleep diagnostic center’s compliance program must verify that its own portion of this documentation, particularly the adherence evaluation, satisfies Medicare’s specific requirements.

This article explains the twelve-week adherence trial structure and its objective usage threshold, the required in-person clinical re-evaluation, the continued coverage requirements beyond the initial trial, why this documentation area draws sustained TPE and RAC attention, and how sleep diagnostic centers should structure an effective documentation review program addressing PAP therapy compliance. It closes with how HealthBridge US supports Sleep Diagnostic Centers strengthening PAP therapy compliance documentation.

The Twelve-Week Adherence Trial Structure

Medicare covers an initial twelve-week trial of PAP therapy for beneficiaries diagnosed with obstructive sleep apnea, and coverage beyond this trial period depends on demonstrating adherence to therapy during the trial itself. Adherence is defined as use of the PAP device for at least four hours per night on at least seventy percent of nights during any consecutive thirty-day period occurring within the first three months of therapy, and documentation should specifically reflect this objective usage data, typically drawn from the device’s own compliance monitoring data, rather than relying on the beneficiary’s self-reported usage alone.

The Required In-Person Clinical Re-Evaluation

The treating physician must conduct an in-person visit with the beneficiary no sooner than the thirty-first day and no later than the ninety-first day after initiating therapy, and this visit must include a clinical re-evaluation documenting that the beneficiary is benefiting from PAP therapy. Documentation from this visit should specifically reference the objective adherence data reviewed and the clinical basis for the physician’s conclusion that continued therapy is appropriate, rather than a brief note confirming only that the visit occurred without addressing the substantive adherence and benefit determination this visit is intended to establish.

Continued Coverage Requirements Beyond the Initial Trial

Beyond the initial twelve-week trial, continued Medicare coverage of PAP therapy depends on an in-person visit with the treating physician who documents in the medical record that the beneficiary continues to meet the applicable coverage conditions and that the therapy continues to provide clinical benefit. Documentation supporting continued coverage should specifically address both of these elements, since a re-evaluation addressing only ongoing device use without a corresponding clinical benefit determination would not fully satisfy this continued coverage documentation standard.

Re-Qualification Following an Initial Trial Failure

Beneficiaries who do not meet the adherence threshold during the initial twelve-week trial may re-qualify for PAP therapy, but doing so requires both an in-person clinical re-evaluation by the treating practitioner addressing the reason for the initial failure to adequately respond to therapy, and a repeat sleep test performed in a facility-based setting. Documentation supporting a re-qualification claim should specifically address both of these required elements, since a re-qualification claim lacking either the re-evaluation addressing the failure’s etiology or the repeat facility-based testing would not satisfy this distinct coverage pathway.

Why PAP Therapy Documentation Draws Sustained TPE and RAC Attention

Because PAP therapy coverage depends on a multi-stage documentation sequence spanning diagnostic testing, adherence monitoring, and ongoing clinical re-evaluation, reviewing contractors examine whether objective adherence data supports the specific usage threshold required, whether the required in-person re-evaluation visits occurred within the applicable timeframes, and whether continued coverage documentation addresses both device use and clinical benefit. TPE reviews in particular often focus on this documentation sequence given how frequently incomplete adherence data or missed re-evaluation timeframes appear across sleep diagnostic centers and their affiliated DME suppliers.

Building an Effective Documentation Review Program

An effective documentation review program should verify, for a representative sample of PAP therapy patients, that objective adherence data was reviewed and documented, that the required in-person re-evaluation occurred within the applicable thirty-one to ninety-one day window, and that continued coverage documentation beyond the initial trial addresses both ongoing use and clinical benefit. The review should specifically flag any patient record lacking clear documentation of the objective adherence data underlying the physician’s continued coverage determination, since this data represents the foundational evidence supporting the entire continued coverage decision.

Common PAP Therapy Documentation Gaps

Several recurring gaps appear in this documentation area. In-person re-evaluation visits occurring outside the required thirty-one to ninety-one day window represent a frequently cited issue, particularly where scheduling delays push this visit beyond the required timeframe. Documentation that references adherence without including the specific objective usage data supporting that conclusion represents another significant gap, particularly where the sleep diagnostic center and the DME supplier maintain separate records without clear coordination. Re-qualification claims lacking either the required clinical re-evaluation addressing the failure’s etiology or the repeat facility-based sleep test round out a frequent finding in this area, along with continued coverage documentation addressing only device usage without a corresponding clinical benefit determination.

Building a Recurring Internal Audit Addressing PAP Documentation

Sleep diagnostic centers benefit from a recurring internal audit specifically sampling PAP therapy patients across each stage of the documentation sequence, verifying that adherence data, re-evaluation timing, and continued coverage documentation are each properly captured and coordinated with the affiliated DME supplier’s own records. This recurring review is particularly valuable given how many distinct timing requirements this documentation sequence involves, since a gap identified early in the process can often still be corrected before it affects a beneficiary’s continued coverage eligibility.

Coordinating Documentation Between the Sleep Center and DME Supplier

Because PAP therapy compliance documentation spans both the sleep diagnostic center’s clinical evaluation and the DME supplier’s device usage data, these two parties should maintain a coordinated process for sharing adherence data and re-evaluation scheduling reminders, ensuring the physician conducting the required in-person visit has ready access to the objective usage data needed to support the visit’s documentation. A chart audit reviewing PAP therapy claims should verify that this coordination is functioning effectively, since a breakdown in communication between these two parties represents a frequently cited root cause behind incomplete adherence documentation.

Training Physicians on Adherence Documentation Expectations

Because the required in-person re-evaluation depends on the physician specifically documenting both objective adherence data and a clinical benefit determination, treating physicians should receive targeted training on these specific documentation expectations, ensuring their visit notes explicitly reference the reviewed usage data and the clinical basis supporting continued therapy. Physicians who understand this specific documentation structure are better positioned to generate visit notes that clearly withstand a subsequent TPE or RAC review, rather than notes that address the visit generally without connecting it to the specific coverage criteria this visit must establish.

Building a Scheduling System to Track Re-Evaluation Timing

Given how narrowly defined the thirty-one to ninety-one day re-evaluation window is, sleep diagnostic centers should build a scheduling system that proactively flags each patient’s applicable window based on their specific therapy initiation date, prompting outreach to schedule the required visit well before the window closes. This proactive scheduling approach reduces the risk of a missed re-evaluation window that could otherwise jeopardize the beneficiary’s continued PAP therapy coverage despite genuine clinical adherence to the prescribed therapy.

Addressing Documentation for Beneficiaries Requiring Bi-Level or Alternative Devices

Where a beneficiary transitions from standard CPAP to a bi-level device due to inadequate response or tolerance, documentation should specifically address the clinical basis for this transition, including the specific findings supporting why standard CPAP proved insufficient. A chart audit addressing device transitions should verify that this clinical rationale is clearly documented, since a transition to a more complex, typically higher-cost device without corresponding documentation explaining its necessity may draw particular attention during a TPE or RAC review examining device selection appropriateness.

Addressing Documentation for Beneficiaries With Mixed or Central Sleep Apnea Findings

Where a beneficiary’s diagnostic testing reveals a mixed presentation involving both obstructive and central sleep apnea components, documentation supporting PAP therapy should specifically address how this mixed presentation was considered in device selection and the adherence and benefit determinations made throughout the trial and continued coverage process. A chart audit examining these mixed-presentation cases should verify that the physician’s documentation reflects genuine consideration of the central component’s potential impact on therapy response, rather than treating the case identically to a straightforward obstructive sleep apnea presentation without acknowledging this added clinical complexity.

Training Front Office and Scheduling Staff on Adherence Data Retrieval

Because the required in-person re-evaluation visit depends on the treating physician having timely access to objective adherence data before or during the visit itself, front office and scheduling staff should receive training on retrieving this data from the DME supplier or device manufacturer’s compliance monitoring platform well in advance of each scheduled re-evaluation appointment. Staff who understand this retrieval process help ensure the physician is never placed in the position of conducting a required re-evaluation visit without the objective data necessary to support a defensible continued coverage determination.

Building a Complete PAP Therapy Documentation File

Sleep diagnostic centers should maintain a complete, organized file for each PAP therapy patient spanning the initial diagnostic testing supporting the OSA diagnosis, the objective adherence data collected during the twelve-week trial, the required in-person re-evaluation visit notes, and any subsequent continued coverage or re-qualification documentation, ensuring this file remains readily accessible if a TPE reviewer or RAC auditor requests documentation addressing a specific patient’s PAP therapy claim history. A well-organized file spanning this full sequence supports a considerably more efficient response than reconstructing this documentation from disparate sources, particularly where the sleep diagnostic center and DME supplier maintain separate recordkeeping systems that must be reconciled only after a formal TPE or RAC request has already been received and a response deadline is already running.

How HealthBridge US Supports Your Sleep Diagnostic Center

PAP therapy coverage depends on a coordinated documentation sequence spanning the twelve-week adherence trial, required in-person re-evaluations, and continued coverage determinations. HealthBridge US supports Sleep Diagnostic Centers with PAP therapy documentation audits, adherence data coordination review, and TPE and RAC audit preparation support. If your center wants to strengthen PAP therapy documentation, verify re-evaluation timing compliance, or needs support preparing for an active TPE or RAC review, HealthBridge US is here to help — contact our team to discuss your center’s compliance needs.

References

• Centers for Medicare & Medicaid Services. National Coverage Determination 240.4, “Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA).” https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=226

• Centers for Medicare & Medicaid Services. Local Coverage Determination: “Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea” (L33718). https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33718

• Centers for Medicare & Medicaid Services. “Positive Airway Pressure (PAP) Devices Coverage Fact Sheet” (ICN 905064). https://www.cms.gov/files/document/papdoccvgfactsheeticn905064textonlypdf

• Centers for Medicare & Medicaid Services. “Targeted Probe and Educate.” https://www.cms.gov/medicare/audits-compliance/fee-service-compliance/targeted-probe-educate

• Centers for Medicare & Medicaid Services. “Recovery Audit Program.” https://www.cms.gov/medicare/audits-compliance/fee-service-compliance/recovery-audit-program

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 29 (Appeals). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c29.pdf

HealthBridge US is here to help. Our compliance specialists support Sleep Diagnostic Centers with PAP therapy documentation review and TPE and RAC audit support — contact us to protect your center’s reimbursement.